InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,648.40
(
1.01%
)
US TECH 100
19,050.40
(
1.19%
)
Dow Jones
41,563.08
(
0.55%
)
Brent Oil
76.25
(
-0.10%
)
Bitcoin
57,674.89
(
0.60%
)
Post# of 253006
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

frontiers

Send PM Follow Ignore
Followers 21
Posts 590
Boards Moderated 0
Alias Born 11/12/2009

frontiers

Re: frontiers post# 179216

Thursday, 06/12/2014 5:24:13 PM

Thursday, June 12, 2014 5:24:13 PM

Post# of 253006
ACHN -- adding to my reply.

Merck ran DDI studies and POLRMT assay with IDX 21437.

The main piece of info lacking with 3422 as I pointed out in earlier post is log 10 viral kill rate in human studies. Those trials are ongoing and results due in 5-6 months. Any prospective buyers will want these results. It's possible that ACHN did get some low-ball offers in the recent past and opted to wait it out for the trial results, much as IDIX did.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up